Contributions
Abstract: EP1371
Type: ePoster
Abstract Category: Clinical aspects of MS - Epidemiology
Objective: Recent studies worldwide demonstrate an association between Multiple Sclerosis (MS) and Restless Leg Syndrome (RLS). The aim of this study was to determine the prevalence RLS in Puerto Rican patients already diagnosed with MS and to assess how demographic factors affect both conditions.
Methods: A cross-sectional study was conducted with 50 MS patients diagnosed using the McDonald Criteria at the San Juan MS Center. These face-to-face interviews were conducted anonymously with consenting patients at the center by assigning them each a code number for identification and confidentiality. Patients were first given the 2012 Revised IRLSSG Diagnostic Criteria for RLS in order to determine an RLS diagnosis. Patients with a 5/5 in the diagnostic criteria were then administered The International Restless Legs Syndrome Study Group rating scale for the severity of restless legs syndrome (IRLS). Collected data included patient"s age, sex, level of education, year of diagnosis, medications being taken for MS, drinking and smoking habits, and town from which the subject"s reside.
Results: Of the 50 MS patients interviewed, 19 were positive for RLS, representing an estimated prevalence of 38%. Of the 19 patients with RLS, there were 4 males (8%) and 15 females (30%). In terms of RLS severity, 26.3% of patients had a moderate score (11-20), 52.6% had a severe score (21-30), and 21.1 % with a very severe score (31-40). None of the patients had mild RLS. None of the positive patients used alcohol and only 2 out of 19 were active smokers.
Conclusion: The estimated prevalence of RLS in Puerto Rican MS patients is 38% and is within the range established in different patient populations reported by other studies. Sleep-related disorders such as RLS have shown to have a negative impact on patient quality of life, especially their energy and emotional state. The results of this study will help guide intervention and diagnostic guidelines to improve quality of life of MS patients in Puerto Rico and worldwide.
Disclosure: Dr. Chinea is a speaker and consultant for Biogen, Allergan, Novartis, Teva, Genzyme Sanofi. Dr. Chinea also received grants from Novartis.
Abstract: EP1371
Type: ePoster
Abstract Category: Clinical aspects of MS - Epidemiology
Objective: Recent studies worldwide demonstrate an association between Multiple Sclerosis (MS) and Restless Leg Syndrome (RLS). The aim of this study was to determine the prevalence RLS in Puerto Rican patients already diagnosed with MS and to assess how demographic factors affect both conditions.
Methods: A cross-sectional study was conducted with 50 MS patients diagnosed using the McDonald Criteria at the San Juan MS Center. These face-to-face interviews were conducted anonymously with consenting patients at the center by assigning them each a code number for identification and confidentiality. Patients were first given the 2012 Revised IRLSSG Diagnostic Criteria for RLS in order to determine an RLS diagnosis. Patients with a 5/5 in the diagnostic criteria were then administered The International Restless Legs Syndrome Study Group rating scale for the severity of restless legs syndrome (IRLS). Collected data included patient"s age, sex, level of education, year of diagnosis, medications being taken for MS, drinking and smoking habits, and town from which the subject"s reside.
Results: Of the 50 MS patients interviewed, 19 were positive for RLS, representing an estimated prevalence of 38%. Of the 19 patients with RLS, there were 4 males (8%) and 15 females (30%). In terms of RLS severity, 26.3% of patients had a moderate score (11-20), 52.6% had a severe score (21-30), and 21.1 % with a very severe score (31-40). None of the patients had mild RLS. None of the positive patients used alcohol and only 2 out of 19 were active smokers.
Conclusion: The estimated prevalence of RLS in Puerto Rican MS patients is 38% and is within the range established in different patient populations reported by other studies. Sleep-related disorders such as RLS have shown to have a negative impact on patient quality of life, especially their energy and emotional state. The results of this study will help guide intervention and diagnostic guidelines to improve quality of life of MS patients in Puerto Rico and worldwide.
Disclosure: Dr. Chinea is a speaker and consultant for Biogen, Allergan, Novartis, Teva, Genzyme Sanofi. Dr. Chinea also received grants from Novartis.